Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01780870 · ClinicalTrials.gov registry record · NA
Weight Loss Study-Mechanism Underlying the Improvement of Insulin Resistance in Response to Weight Loss
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT01780870: Completed NA study, sponsored by Beth Israel Deaconess Medical Center.
NCT01780870 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01780870, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The main purpose of this study is to assess factors mediating the changes in insulin sensitivity and glucose tolerance before and after 10 lbs ± or 2% weight loss reduction as well as 2, 3, 6, 12, and 24 months after initiation of a low calorie diet. The investigators will also study the following: 1. The impact of diet induced weight loss on hormones/adipokine levels 2. The impact of diet induced weight loss on leptin tolerance
Primary Outcome
The secondary outcome was deleted, since it was finally not performed in the study due to problems in enrollment
Interventions
- DIETARY_SUPPLEMENT Weight loss group (Full meal replacement products)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2012-09 |
| Est. Completion | 2017-01 |
| Phase | NA |
What the finished NCT01780870 record still lists
NCT01780870 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Weight loss group (Full meal replacement products) is the first listed.
NCT01780870 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01780870 about?
NCT01780870 is a clinical study titled "Weight Loss Study-Mechanism Underlying the Improvement of Insulin Resistance in Response to Weight Loss". The main purpose of this study is to assess factors mediating the changes in insulin sensitivity and glucose tolerance before and after 10 lbs ± or 2% weight loss reduction as well as 2, 3, 6, 12, and 24 months after initiation of a low calorie diet. The investigators will also study the following:...
What is the current status of trial NCT01780870?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2012-09. Estimated completion is 2017-01.
What interventions are being tested in trial NCT01780870?
The interventions under investigation include: Weight loss group (Full meal replacement products) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01780870?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01780870's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia